chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Monocyte count increased, Monocyte percentage increased, Neutrophil count normal, Neutrophil percentage, Platelet count normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Pyrexia, Red blood cell count normal, Red blood cell sedimentation rate normal, Red cell distribution width normal, Troponin T
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Troponin increased, White blood cell count normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Basophil percentage decreased, Blood creatine phosphokinase MB increased, C-reactive protein increased, Chest pain, Dyspnoea
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Eosinophil count decreased, Haematocrit normal, Haemoglobin normal, Headache, Lymphocyte percentage decreased
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Mean cell volume normal, Mean platelet volume decreased, Monocyte percentage increased, Pyrexia, Red blood cell count normal
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: This case was received on 30 July 2010 via QScan search of the VAERS database, under reference number 385539. A 20-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000, lot number W04003A, and anthrax vaccine (Michigan Department of Public Health, lot number FAV213). On 17 April 2010, 10 days post-vaccination, the patient woke up with chest pain, headache, fever, and trouble deep breathing due to pain in chest. laboratory testing revealed the following: WBC 9.0 x 10 (3)/mcL; RBC 4.75 x 10 (6)/mcL; hemoglobin 15.3g/dL; hematocrit 42.8%; MCV 90.1 fL. In addition C-reactive protein was increased, basophil percentage decreased, monocyte percentage increased, blood creating phosphokinase MB increased, eosinophil count decreased, troponin increased, lymphocyte percentage decreased, and mean platelet volume decreased. The patient was admitted to the hospital, and subsequently recovered. Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Angiogram pulmonary normal, Basophil count decreased, Basophil percentage decreased, Blood creatine phosphokinase MB increased, Blood creatine phosphokinase normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: C-reactive protein increased, Chest X-ray normal, Chest discomfort, Chest pain, Computerised tomogram normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Differential white blood cell count, Dyspnoea, Echocardiogram normal, Eosinophil count decreased, Eosinophil count normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Haematocrit normal, Haemoglobin normal, Headache, Laboratory test abnormal, Lymphocyte count normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin increased, Mean cell volume normal, Mean platelet volume decreased
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Monocyte count increased, Monocyte percentage increased, Neutrophil count normal, Neutrophil percentage, Platelet count normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Pyrexia, Red blood cell count normal, Red blood cell sedimentation rate normal, Red cell distribution width normal, Troponin T
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Troponin increased, White blood cell count normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Basophil percentage decreased, Blood creatine phosphokinase MB increased, C-reactive protein increased, Chest pain, Dyspnoea
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Eosinophil count decreased, Haematocrit normal, Haemoglobin normal, Headache, Lymphocyte percentage decreased
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Mean cell volume normal, Mean platelet volume decreased, Monocyte percentage increased, Pyrexia, Red blood cell count normal
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: This report was received from the investigator in a trial on 04 August 2010.  A 20 year-old male subject, with no significant past medical history, had received the following vaccines on 07 April 2010: ACAM2000, (lot number not reported) and ANTHRAX (trade name, manufacturer name and lot number not reported).  The subject was vaccinated with TYPHIM VI (lot number not reported) thirteen days prior.  On 17 April 2010, diagnostic testing revealed abnormal ECG and normal echocardiogram.  MRI (of the brain, spine and heart), and lumbar puncture were not performed.  On 18 April 2010, laboratory data revealed abnormal Troponin 1 with highest value of 00.16.  On 23 April 2010 (sixteen days after receiving the smallpox vaccination), the subject was diagnosed with non-specific myocarditis.  No other information was provided.  Additional information will be requested from the investigator.  Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Breath odour, Erythema multiforme, Oropharyngeal pain, Rash, Skin lesion
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 386087. A 24-year-old male patient received the following vaccinations on 07 April 2010: ACAM2000 (lot number W04003A), TYPHIM VI (lot number B1026), and anthrax vaccine (Michigan Department of Public Health, lot number FAV230). On 10 April 2010, 6 days post-vaccination, the patient developed "a few bumps". Over the next several days he developed multiple lesions over his elbows, hands, fingers, knees, and palms. He also complained of a sore throat with odor. He required an emergency room visit, and "rash per pcm almost looks like EM or a Strep A rash". Subsequent diagnoses included erythema multiforme. No other symptoms were noted. Outcome was not reported. Note: Anthrax vaccine manufacturer was likely incorrectly reported in VAERS.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chest X-ray, Cough, Dyspnoea, Electrocardiogram, Feeling abnormal
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 386118.  A 21-year-old male patient received the following vaccines on 20 April 2010: ACAM2000 (lot number VV04-003A), TYPHIM VI (lot number B1026-2) and BIOTHRAX (Emergent Biosolutions, lot number FAV226).  Seven days post-vaccination, the patient reported "feeling lousy", with symptoms of cough, shortness of breath, and possible spread to the left nipple.  He was seen in the emergency room and screened for carditis due to shortness of breath, undergoing a chest x-ray, EKG, and labs (results not reported).  Per the reporter, carditis was not "overly suspected".  The plan was to monitor the left nipple for oozing; outcome was not reported.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Laboratory test
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 386118.  A 21-year-old male patient received the following vaccines on 20 April 2010: ACAM2000 (lot number VV04-003A), TYPHIM VI (lot number B1026-2) and BIOTHRAX (Emergent Biosolutions, lot number FAV226).  Seven days post-vaccination, the patient reported "feeling lousy", with symptoms of cough, shortness of breath, and possible spread to the left nipple.  He was seen in the emergency room and screened for carditis due to shortness of breath, undergoing a chest x-ray, EKG, and labs (results not reported).  Per the reporter, carditis was not "overly suspected".  The plan was to monitor the left nipple for oozing; outcome was not reported.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Breast discharge, Carditis, Chest X-ray, Cough, Dyspnoea
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 386118.  A 21-year-old male patient received the following vaccines on 20 April 2010: ACAM2000 (lot number VV04-003A), TYPHIM VI (lot number B1026-2) and BIOTHRAX (Emergent Biosolutions, lot number FAV226).  Seven days post-vaccination, the patient reported "feeling lousy", with symptoms of cough, shortness of breath, and possible spread to the left nipple.  He was seen in the emergency room and screened for carditis due to shortness of breath, undergoing a chest x-ray, EKG, and labs (results not reported).  Per the reporter, carditis was not "overly suspected".  The plan was to monitor the left nipple for oozing; outcome was not reported.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Electrocardiogram, Feeling abnormal, Laboratory test
Clinical narrative: This case was received on 30 July 2010 via a QScan search on the VAERS database, under reference number 386118.  A 21-year-old male patient received the following vaccines on 20 April 2010: ACAM2000 (lot number VV04-003A), TYPHIM VI (lot number B1026-2) and BIOTHRAX (Emergent Biosolutions, lot number FAV226).  Seven days post-vaccination, the patient reported "feeling lousy", with symptoms of cough, shortness of breath, and possible spread to the left nipple.  He was seen in the emergency room and screened for carditis due to shortness of breath, undergoing a chest x-ray, EKG, and labs (results not reported).  Per the reporter, carditis was not "overly suspected".  The plan was to monitor the left nipple for oozing; outcome was not reported.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Catheter placement, Chest discomfort, Culture wound, Injection site reaction, Myocarditis
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID # 386659. A 37 year-old male patient received the following vaccination on 17 April 2010, the patient presented with chest discomfort. Due to his elevated Troponin he was evaluated with a computed axial tomography scan which showed no evidence of pulmonary embolism. He subsequently went to the heart catheterization lab and underwent heart catheterization disclosing no significant obstructive coronary disease. The patient had a wound culture, vaccinia polymerase chain reaction and an electrocardiogram performed. The patient had cardiac enzymes drawn and troponin levels were elevated. The patient was seen by Infectious Disease due to abnormal left deltoid at the site of his recent smallpox vaccination. The CDC was involved through doctor conversations and evaluation of photographs of the deltoid lesion. The patient was doing well and was scheduled to be discharged later today (date not provided). A follow-up visit with a doctor was to be within one week. He will follow-up in two or three weeks and will have an echocardiogram and plain treadmill stress test to determine if he could return to work without restriction. The patient was believed to have had myocarditis secondary to his smallpox vaccination due to the appropriate timing. The clinical picture was definitely consistent with myocarditis. The outcome was reported as unknown. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Polymerase chain reaction, Skin lesion, Troponin increased, Vaccination complication
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID # 386659. A 37 year-old male patient received the following vaccination on 17 April 2010, the patient presented with chest discomfort. Due to his elevated Troponin he was evaluated with a computed axial tomography scan which showed no evidence of pulmonary embolism. He subsequently went to the heart catheterization lab and underwent heart catheterization disclosing no significant obstructive coronary disease. The patient had a wound culture, vaccinia polymerase chain reaction and an electrocardiogram performed. The patient had cardiac enzymes drawn and troponin levels were elevated. The patient was seen by Infectious Disease due to abnormal left deltoid at the site of his recent smallpox vaccination. The CDC was involved through doctor conversations and evaluation of photographs of the deltoid lesion. The patient was doing well and was scheduled to be discharged later today (date not provided). A follow-up visit with a doctor was to be within one week. He will follow-up in two or three weeks and will have an echocardiogram and plain treadmill stress test to determine if he could return to work without restriction. The patient was believed to have had myocarditis secondary to his smallpox vaccination due to the appropriate timing. The clinical picture was definitely consistent with myocarditis. The outcome was reported as unknown. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Cardiac enzymes increased, Catheterisation cardiac normal, Chest discomfort, Computerised tomogram normal, Culture wound
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID # 386659. A 37 year-old male patient received the following vaccination on 17 April 2010, the patient presented with chest discomfort. Due to his elevated Troponin he was evaluated with a computed axial tomography scan which showed no evidence of pulmonary embolism. He subsequently went to the heart catheterization lab and underwent heart catheterization disclosing no significant obstructive coronary disease. The patient had a wound culture, vaccinia polymerase chain reaction and an electrocardiogram performed. The patient had cardiac enzymes drawn and troponin levels were elevated. The patient was seen by Infectious Disease due to abnormal left deltoid at the site of his recent smallpox vaccination. The CDC was involved through doctor conversations and evaluation of photographs of the deltoid lesion. The patient was doing well and was scheduled to be discharged later today (date not provided). A follow-up visit with a doctor was to be within one week. He will follow-up in two or three weeks and will have an echocardiogram and plain treadmill stress test to determine if he could return to work without restriction. The patient was believed to have had myocarditis secondary to his smallpox vaccination due to the appropriate timing. The clinical picture was definitely consistent with myocarditis. The outcome was reported as unknown. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram, Impaired work ability, Injection site reaction, Myocarditis, Polymerase chain reaction
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID # 386659. A 37 year-old male patient received the following vaccination on 17 April 2010, the patient presented with chest discomfort. Due to his elevated Troponin he was evaluated with a computed axial tomography scan which showed no evidence of pulmonary embolism. He subsequently went to the heart catheterization lab and underwent heart catheterization disclosing no significant obstructive coronary disease. The patient had a wound culture, vaccinia polymerase chain reaction and an electrocardiogram performed. The patient had cardiac enzymes drawn and troponin levels were elevated. The patient was seen by Infectious Disease due to abnormal left deltoid at the site of his recent smallpox vaccination. The CDC was involved through doctor conversations and evaluation of photographs of the deltoid lesion. The patient was doing well and was scheduled to be discharged later today (date not provided). A follow-up visit with a doctor was to be within one week. He will follow-up in two or three weeks and will have an echocardiogram and plain treadmill stress test to determine if he could return to work without restriction. The patient was believed to have had myocarditis secondary to his smallpox vaccination due to the appropriate timing. The clinical picture was definitely consistent with myocarditis. The outcome was reported as unknown. Documents held by sender: None.
Age: 37.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Skin lesion, Troponin increased
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number VAERS ID # 386659. A 37 year-old male patient received the following vaccination on 17 April 2010, the patient presented with chest discomfort. Due to his elevated Troponin he was evaluated with a computed axial tomography scan which showed no evidence of pulmonary embolism. He subsequently went to the heart catheterization lab and underwent heart catheterization disclosing no significant obstructive coronary disease. The patient had a wound culture, vaccinia polymerase chain reaction and an electrocardiogram performed. The patient had cardiac enzymes drawn and troponin levels were elevated. The patient was seen by Infectious Disease due to abnormal left deltoid at the site of his recent smallpox vaccination. The CDC was involved through doctor conversations and evaluation of photographs of the deltoid lesion. The patient was doing well and was scheduled to be discharged later today (date not provided). A follow-up visit with a doctor was to be within one week. He will follow-up in two or three weeks and will have an echocardiogram and plain treadmill stress test to determine if he could return to work without restriction. The patient was believed to have had myocarditis secondary to his smallpox vaccination due to the appropriate timing. The clinical picture was definitely consistent with myocarditis. The outcome was reported as unknown. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Burning sensation, Lymphadenopathy, Paraesthesia, Rash
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 386702.  A 19-year-old male patient received the following vaccinations on 27 April 2010: a first left arm injection of ACAM2000 (lot number W04003A); a first right arm injection of TYPHIM VI (lot number D0191); and a first right arm injection of BIOTHRAX (anthrax vaccine, Emergent Biosolutions, lot number FAV223).  On 04 May 2010, 7 days post-vaccination, the patient developed a rash, burning and prickling sensation above the left eye, and a swollen lymph node behind the left ear.  The events required an emergency visit, and the patient subsequently recovered.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Condition aggravated, Decreased appetite, Diarrhoea, Fatigue, Heart rate irregular
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 387051. A 28-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04003A) on 23 February 2010. He had a history of migraine headaches, and was taking MAXALT concomitantly. He denied any illness at the time of vaccination. On day post vaccination, on 24 February 2010, the patient developed a migraine headache, followed by nausea, vomiting and diarrhea. He was seen on 23 March 2010, the patient 2-week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever and non-healing smallpox vaccine injection site. He required hospital admission. On 05 April 2010 the smallpox vaccine injection site was healing, and the patient was being followed by neurology due to intractable headache. The reporter had attempted to contact the patient, but had received no response. Outcome was unknown.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site reaction, Malaise, Migraine, Nausea, Pain
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 387051. A 28-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04003A) on 23 February 2010. He had a history of migraine headaches, and was taking MAXALT concomitantly. He denied any illness at the time of vaccination. On day post vaccination, on 24 February 2010, the patient developed a migraine headache, followed by nausea, vomiting and diarrhea. He was seen on 23 March 2010, the patient 2-week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever and non-healing smallpox vaccine injection site. He required hospital admission. On 05 April 2010 the smallpox vaccine injection site was healing, and the patient was being followed by neurology due to intractable headache. The reporter had attempted to contact the patient, but had received no response. Outcome was unknown.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pyrexia, Tremor, Vomiting
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 387051. A 28-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04003A) on 23 February 2010. He had a history of migraine headaches, and was taking MAXALT concomitantly. He denied any illness at the time of vaccination. On day post vaccination, on 24 February 2010, the patient developed a migraine headache, followed by nausea, vomiting and diarrhea. He was seen on 23 March 2010, the patient 2-week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever and non-healing smallpox vaccine injection site. He required hospital admission. On 05 April 2010 the smallpox vaccine injection site was healing, and the patient was being followed by neurology due to intractable headache. The reporter had attempted to contact the patient, but had received no response. Outcome was unknown.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Condition aggravated, Decreased appetite, Diarrhoea, Fatigue, Headache
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 387051. A 28-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04003A) on 23 February 2010. He had a history of migraine headaches, and was taking MAXALT concomitantly. He denied any illness at the time of vaccination. On day post vaccination, on 24 February 2010, the patient developed a migraine headache, followed by nausea, vomiting and diarrhea. He was seen on 23 March 2010, the patient 2-week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever and non-healing smallpox vaccine injection site. He required hospital admission. On 05 April 2010 the smallpox vaccine injection site was healing, and the patient was being followed by neurology due to intractable headache. The reporter had attempted to contact the patient, but had received no response. Outcome was unknown.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Heart rate irregular, Injection site reaction, Malaise, Migraine, Nausea
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 387051. A 28-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04003A) on 23 February 2010. He had a history of migraine headaches, and was taking MAXALT concomitantly. He denied any illness at the time of vaccination. On day post vaccination, on 24 February 2010, the patient developed a migraine headache, followed by nausea, vomiting and diarrhea. He was seen on 23 March 2010, the patient 2-week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever and non-healing smallpox vaccine injection site. He required hospital admission. On 05 April 2010 the smallpox vaccine injection site was healing, and the patient was being followed by neurology due to intractable headache. The reporter had attempted to contact the patient, but had received no response. Outcome was unknown.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pain, Pyrexia, Tremor, Vomiting
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 387051. A 28-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04003A) on 23 February 2010. He had a history of migraine headaches, and was taking MAXALT concomitantly. He denied any illness at the time of vaccination. On day post vaccination, on 24 February 2010, the patient developed a migraine headache, followed by nausea, vomiting and diarrhea. He was seen on 23 March 2010, the patient 2-week history of hand tremors, fluctuation in heart rate, malaise, fatigue, poor appetite, diarrhea, body aches, fever and non-healing smallpox vaccine injection site. He required hospital admission. On 05 April 2010 the smallpox vaccine injection site was healing, and the patient was being followed by neurology due to intractable headache. The reporter had attempted to contact the patient, but had received no response. Outcome was unknown.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema multiforme, Rash, Rash pruritic
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 389291. A 23-year-old female patient received a first left arm percutaneous dose of smallpox (vaccinia) vaccine, live (ACAM2000, lot number and route of administration not reported) on 15 March 2010. On 10 April 2010 the patient developed an itching skin rash coupled with multiforme that began on the scalp and spread to the arms and upper trunk. The patient responded initially to steroids. Outcome was reported as not recovered. Other medications were reported as morphine and YASMIN. The patient had no concurrent illnesses at time of vaccination, and had a history of allergic rhinitis, and nicotine dependence. Documents held by sender: None
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema multiforme, Pruritus, Rash
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 389291. A 23-year-old female patient received a first left arm percutaneous dose of smallpox (vaccinia) vaccine, live (ACAM2000, lot number and route of administration not reported) on 15 March 2010. On 10 April 2010 the patient developed an itching skin rash coupled with multiforme that began on the scalp and spread to the arms and upper trunk. The patient responded initially to steroids. Outcome was reported as not recovered. Other medications were reported as morphine and YASMIN. The patient had no concurrent illnesses at time of vaccination, and had a history of allergic rhinitis, and nicotine dependence. Documents held by sender: None
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Atrial fibrillation, Chest pain, Dyspnoea, Palpitations, Tachycardia
Clinical narrative: This case was received on 09 August 2010 via a QScan search on the VAERS database, under reference number 389467. A 34-year-old male patient received smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV4003A) on 07 September 2008. On 01 October 2008, 24 days post-vaccination, the patient complained of chest pain, shortness of breath, and palpitations. The condition developed into a chronic atrial fibrillation condition. Symptoms included chest pain, palpitations, and tachycardia. The patient had not recovered. No other information was provided.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Electrocardiogram abnormal, Pericardial disease, Troponin I increased
Clinical narrative: A Phase IV Enhanced Safety Surveillance Study of ACAM 2000. This report was received from the investigator (MILVAX) in the above mention trial on 07 June 2010. A 20 year-old male subject who no significant medical history received the following vaccines on 13 March 2010: smallpox (vaccinia) vaccine, live (ACAM2000, lot number not reported); and Anthrax vaccine (other manufacturer and lot number not reported). Sixteen days after vaccination, the subject was diagnosed with unspecified disease of the pericardium. On Day 11 (24 March 2010), the subject had an abnormal electrocardiogram. On Day 14 (27 March 2010), the subject had a Troponin I of 1.29 (abnormal). The outcome was not reported. Additional information will be requested from the investigator. There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Acute myocardial infarction, Electrocardiogram abnormal, Troponin I increased
Clinical narrative: A Phase IV Enhanced Safety Surveillance Study of ACAM2000 in Military Personnel Subject Number: 5000065. This report was received from the investigator (MILVAX) in the above mentioned trial on 07 June 2010. A 26 year-old male subject with no significant medical history received the following vaccines on 07 January 2010: smallpox (vaccinia) vaccine, live (ACAM2000, lot number not reported); and anthrax vaccine (other manufacturer and lot number not reported). Eleven days after vaccination, the subject was diagnosed with an acute myocardial infarction (subendocardial infarction). On day 11 (18 January 2010), the subject had a Troponin I of 0.45 (abnormal) and an abnormal electrocardiogram. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None
Age: 28.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Pericarditis, Troponin I
Clinical narrative: This report was received from the investigator in a trial on 07 June 2010.  A 28 year-old female subject with a medical history of dizziness or fainting spells and numbness or paralysis received ACAM2000 (lot number not reported) on 12 January 2010.  Fourteen days after vaccination, the subject was diagnosed with acute pericarditis, unspecified.  On Day 14 (26 January 2010), the subject had an abnormal electrocardiogram, and a normal Troponin I and echocardiogram.  The outcome was not reported.  Additional information will be requested from the investigator.  Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study.  List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, FLUX(H1N1), SMALL, TYP, ANTH, FLUX(H1N1), SMALL, TYP
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Pericarditis, Troponin I increased
Clinical narrative: This report was received from the investigator on 07 June 2010. A 20 year-old male subject with no significant medical history received the following vaccines on 27 January 2010: ACAM2000 (lot number not reported); TYPHIM VI (lot number not reported; H1N1 vaccine (manufacturer unknown and lot number not reported); and anthrax vaccine (other manufacturer and lot number not reported). Twenty-five days after vaccination, the subject was diagnosed with acute idiopathic pericarditis. On Day 25 (21 February 2010), the subject had a Troponin I of 6.44 (abnormal); an abnormal electrocardiogram; and a normal echocardiogram. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.